← Association for Accessible Medicines
FDANonrulemakingFDA-2025-N-2786

Biosimilar User Fee Act III Regulatory Science Program Interim Public Meeting; Public Meeting; Request for Comments

RIN
—
Last modified
Oct 22, 2025
Comment window
closed 283d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Oct 22, 2025 and Oct 22, 2025. 0 other organizations filed here. The comment window closed 283d ago.

What Association for Accessible Medicines filed (1)

Oct 22, 2025· Comment from Association for Accessible Medicines· FDA-2025-N-2786-0002

AAM / Biosimilars Council Comment on Biosimilar User Fee Act III Regulatory Science Program Interim Public Meeting

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (0)

See everyone who commented →